Follow the Money: Eyevance Raises $30M, Sanara MedTech Gets $10M, Tyler Technologies Makes Acquisition
Summary
“The acquisition of TOBRADEX ST and NATACYN further demonstrates Eyevance’s commitment and mission to serve the doctors that treat patients’ anterior segment and ocular surface conditions,” Jerry St. Peter, Eyevance’s co-founder, CEO, and director, said in a statement. Fort Worth-based Sanara MedTech has closed a private equity offering worth $10 million in common stock that it plans to use to fund milestones payments under current and future product license agreement, Mass Device reported. Sanara, which markets and distributes wound and skincare products, said it also intends to put the funding toward repaying debts from its bank line of credit, as well as operating expenditures such as clinical studies and sales force expansion, Mass Device said. The startup will leverage the prize money to advance its unique dementia-focused phone service that keeps seniors safely connected with family and friends, protects against elder fraud, and stops phone-related stress, the release said. “In recent years, the importance of social value measurement has grown exponentially globally,” Donald Morrison, Jacobs Buildings and Infrastructure Europe, Middle East and Africa senior vice president said in the release.
